Ca2+-currents in human induced pluripotent stem cell-derived cardiomyocytes - effects of two different culture conditions

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) provide a unique opportunity to study human heart physiology and pharmacology and repair injured hearts. The suitability of hiPSC-CM critically depends on how closely they share physiological properties of human adult cardiomyocyt...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmet Umur Uzun (Author), Ingra Mannhardt (Author), Kaja Breckwoldt (Author), András Horváth (Author), Silke Skytte Johannsen (Author), Arne Hansen (Author), Thomas Eschenhagen (Author), Torsten Christ (Author)
Format: Book
Published: Frontiers Media S.A., 2016-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0a43f8e555364c1abd03a10d442fd5c0
042 |a dc 
100 1 0 |a Ahmet Umur Uzun  |e author 
700 1 0 |a Ahmet Umur Uzun  |e author 
700 1 0 |a Ingra Mannhardt  |e author 
700 1 0 |a Ingra Mannhardt  |e author 
700 1 0 |a Kaja Breckwoldt  |e author 
700 1 0 |a Kaja Breckwoldt  |e author 
700 1 0 |a András Horváth  |e author 
700 1 0 |a András Horváth  |e author 
700 1 0 |a András Horváth  |e author 
700 1 0 |a Silke Skytte Johannsen  |e author 
700 1 0 |a Silke Skytte Johannsen  |e author 
700 1 0 |a Arne Hansen  |e author 
700 1 0 |a Arne Hansen  |e author 
700 1 0 |a Thomas Eschenhagen  |e author 
700 1 0 |a Thomas Eschenhagen  |e author 
700 1 0 |a Torsten Christ  |e author 
700 1 0 |a Torsten Christ  |e author 
245 0 0 |a Ca2+-currents in human induced pluripotent stem cell-derived cardiomyocytes - effects of two different culture conditions 
260 |b Frontiers Media S.A.,   |c 2016-09-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2016.00300 
520 |a Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) provide a unique opportunity to study human heart physiology and pharmacology and repair injured hearts. The suitability of hiPSC-CM critically depends on how closely they share physiological properties of human adult cardiomyocytes (CM). Here we investigated whether a 3D engineered heart tissue (EHT) culture format favors maturation and addressed the L-type Ca2+-current (ICa,L) as a readout. The results were compared with hiPSC-CM cultured in conventional monolayer (ML) and to our previous data from human adult atrial and ventricular CM obtained when identical patch-clamp protocols were used. HiPSC-CM were 2-3 fold smaller than adult CM, independently of culture format (capacitance ML 45±1 pF (n=289), EHT 45±1 pF (n=460), atrial CM 87±3 pF (n=196), ventricular CM 126±8 pF (n=50)). Only 88% of ML cells showed ICa, but all EHT. Basal ICa density was 10±1 pA/pF (n=207) for ML and 12±1 pA/pF (n=361) for EHT and was larger than in adult CM (7±1 pA/pF (p<0.05, n=196) for atrial CM and 6±1 pA/pF (p<0.05, n=47) for ventricular CM). However, ML and EHT showed robust T-type Ca2+-currents (ICa,T). While (-)-Bay K 8644, that activates ICa,L directly, increased ICa,L to the same extent in ML and EHT, β1- and β2-adrenoceptor effects were marginal in ML, but of same size as (-)-Bay K 8644 in EHT. The opposite was true for serotonin receptors. Sensitivity to β1 and β2-adrenoceptor stimulation was the same in EHT as in adult CM (-logEC50: 5.9 and 6.1 for norepinephrine (NE) and epinephrine (Epi), respectively), but very low concentrations of Rp-8-Br-cAMPS were sufficient to suppress effects (-logEC50: 5.3 and 5.3 respectively for NE and Epi). Taken together, hiPSC-CM express ICa,L at the same density as human adult CM, but, in contrast, possess robust ICa,T. Increased effects of catecholamines in EHT suggest more efficient maturation. 
546 |a EN 
690 |a 5-Hydroxytryptamine 
690 |a protein kinase A 
690 |a β-adrenoceptor 
690 |a L-type Ca2+-channel 
690 |a Human induced pluripotent stem cell-derived cardiomyocytes 
690 |a T-type Ca2+-channel 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 7 (2016) 
787 0 |n http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00300/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/0a43f8e555364c1abd03a10d442fd5c0  |z Connect to this object online.